Randomized, Double-Blind, Placebo-Controlled Crossover Trial of Once Daily Empagliflozin 25  mg for the Treatment of Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass

Diabetes Technology&Therapeutics, Ahead of Print.

Source: Diabetes Technology and Therapeutics - June 5, 2023 Category: Endocrinology Authors: Antonio Ferreira Katja A. Sch önenberger Natascha Potoczna Andreas Vogt Philipp A. Gerber J örg Zehetner Daniel Giachino Philipp Nett Joanna Gawinecka Luca Cossu Daniel G. Fuster Chiara Dalla Man Andrea Facchinetti Andreas Melmer Christos T. Nakas Matth Source Type: research